WHAT: Concise, relevant, and practical clinical education for the management of OUD in the ED
WHO: By emergency care providers, for emergency care providers
HOW: A 6-part, interactive, and case-based webinar series with recommended preparatory online material
Thursday, October 28 from 5:30 pm – 6:30 pm
Description: We will review five key clinical skills to integrate into your ED practice to enhance care for patients with opioid use disorder. CME accredited.
Watch the recording here: "Just the Nuggets"
Thursday, November 25 from 5:00 pm – 6:00 pm
Description: In part 2, we will review the management of precipitated withdrawal, emerging approaches to starting buprenorphine/naloxone and micro-inductions. CME accredited.
Tuesday, December 14 from 5:30 pm – 6:30 pm
Description: In part 3, we look to shift the focus to the deeper roots of disproportionate toxic drug crisis impacting First Nations People. CME accredited.
WHY: As part of the LOUD in the ED collaborative, this education series was developed based on evaluation results that demonstrated a need for short and interactive webinars that could highlight some of the foundations to OUD care in the ED setting. For more information, please read below.
The Learning about Opioid Use Disorder (LOUD) in the Emergency Department (ED) quality improvement initiative was a provincial initiative led in partnership between the BC Patient Safety & Quality Council (the Council), BC Centre on Substance Use (BCCSU) and Overdose Emergency Response Centre (OERC) with EDs across BC. This quality improvement initiative aimed to shift how EDs care for individuals with opioid use disorder.
In the context of dual public health emergencies, this initiative launched as a virtual action series to support evidence-based quality care in EDs. The action series focused on four main drivers: recommended clinical decision support tools, clinical education and strategies, people- and provider-centred care, and the connection continuum. The objective and aligned metrics from LOUD in the ED are summarized below.
OBJECTIVE: To improve the experience of Opioid Use Disorder (OUD) care for people and providers. This included reducing the morbidity and mortality for people with OUD in the ED by improving access to evidence-informed care, particularly buprenorphine-naloxone (Suboxone®).
Online Materials: To help support busy ED care providers, the LOUD in the ED collaborative has developed preparatory online material with some of the foundations to providing quality care. (COMING SOON)
To find out more about the LOUD in the ED initiative, read our LOUD in the ED Report.